Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant

Keyphrases

• Toll-like 100%
• Annexin A2 (ANXA2) 100%
• Receptor 2 100%
• Toll-like Receptor 2 (TLR2) 81%
• Amino Acids 27%
• Amino 27%
• Fusion Peptide 18%
• Heterotetramer 18%
• Reporter Cells 18%
• Vaccination 9%
• Glioma 9%
• Tumor-specific 9%
• Mass Spectrometry 9%
• Dendritic Cell Maturation 9%
• Glioblastoma 9%
• Tumor Antigen 9%
• Tissue Distribution 9%
• Cell-to-cell 9%
• Glioma Cells 9%
• Neoantigen 9%
• Interleukin-6 9%
• Under-five 9%
• Myeloid Differentiation Factor 88 (MyD88) 9%
• Binding Protein 9%
• Vaccine Adjuvant 9%
• TLR Agonists 9%
• Toll-like Receptor 4 (TLR4) 9%
• Interleukin-1β 9%
• Binding Region 9%
• Membrane Binding 9%
• Calcium-dependent 9%
• Intracellular Membranes 9%
• CD80 9%
• CD86 9%
• Human Dendritic Cells 9%
• Human Macrophages 9%
• Immature Dendritic Cells 9%
• Amino-terminus 9%
• Murine Macrophages 9%
• Mouse Dendritic Cells 9%
• Chicken Ovalbumin 9%
• Dendritic Cell Activation 9%
• Immunogenic Tumor 9%
• Antigen-specific CD8+ T Cells 9%
• IL-12p70 9%
• GL261 Glioma 9%
• CD8+ T Cell Epitopes 9%
• Antigen Cross-presentation 9%
• Phospholipid-binding Protein 9%
• GL261 Cells 9%
• Peptide Fusion 9%
• Derived Peptide 9%
• Tumor Sequencing 9%

Immunology and Microbiology

• TLR2 100%
• Adjuvant 100%
• Peptides 50%
• Amino Terminal Sequence 40%
• Dendritic Cell 30%
• Amino Acid 30%
• Cytotoxic T-Cell 20%
• Tumor Necrosis Factor 20%
• Protein Binding 20%
• Macrophage 10%
• Neoantigen 10%
• TLR4 10%
• Cross-Presentation 10%
• Vaccine Adjuvant 10%
• Agonist 10%
• Secretion (Process) 10%
• Antigen Specificity 10%
• Cell Maturation 10%
• Epitope 10%
• Glioma Cell 10%
• Cell Activation 10%
• Interleukin 6 10%
• Interleukin 1 10%
• Intracellular Membrane 10%
• CD80 10%
• CD86 10%
• Tissue Distribution 10%
• TRIF 10%
• Tumor Antigen 10%
• In Vitro 10%

Biochemistry, Genetics and Molecular Biology

• Annexin A2 100%
• TLR2 100%
• N-Terminus 36%
• Amino Acids 27%
• Dendritic Cell 27%
• Binding Protein 18%
• Heterotetramer 18%
• T Cell 18%
• Tumor Necrosis Factor 18%
• CD8 18%
• Macrophage 9%
• Interleukin-1 9%
• Agonist 9%
• Secretion (Process) 9%
• Mass Spectrometry 9%
• Cell Activation 9%
• Cell Maturation 9%
• Intracellular Membrane 9%
• Antigen Specificity 9%
• Tissue Distribution 9%
• Cross Presentation 9%
• CD80 9%
• CD86 9%
• TRIF 9%
• Ovalbumin 9%
• Interleukin 6 9%
• TLR4 9%
• Tumor Antigen 9%
• Phospholipid 9%